CLSA Premium Limited provided consolidated earnings guidance for the year ended 31 December 2023. For the year, the company expects the Group to record a consolidated net profit of approximately HKD 7.7 million, as compared with the audited consolidated net loss of approximately HKD 31.1 million for the year ended 31 December 2022. The expected net profit was mainly attributable to the significant growth of healthcare business in the year 2023 with revenue from sales of healthcare products exceeding 3 times that of year 2022.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.07 HKD | -.--% | -.--% | -.--% |
Mar. 20 | CLSA Premium Limited Announces Board and Committee Changes | CI |
Mar. 11 | CLSA Premium Limited Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
-.--% | 18.18M | |
-.--% | 843M | |
-0.79% | 657M | |
+5.50% | 384M | |
+23.83% | 229M | |
0.00% | 141M | |
+134.78% | 65.28M |
- Stock Market
- Equities
- 6877 Stock
- News CLSA Premium Limited
- CLSA Premium Limited Provides Consolidated Earnings Guidance for the Year Ended 31 December 2023